TrialEuropean journal of pediatrics2010

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.

Timo Vesikari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.